Showing results (1001-1010 of 3,868) with videos related to
Sort By:
Pageof 387
Cancer Biology & Therapy|May 27, 2017
Comparison of efficacy between TACE combined with apatinib and TACE alone in the treatment of intermediate and advanced hepatocellular carcinoma: A single-center randomized controlled trialWei Lu, Xin-Li Jin, Chao Yang, et al.Cancer Biology & Therapy|September 10, 2016
Long time response with chemotherapy in ROS1 NSCLC patient with unusual metastatic siteTindara Franchina, Alessandro Russo, Giuseppina Rosaria Ricciardi, et al.Cancer Biology & Therapy|October 27, 2021
NSUN6, an RNA methyltransferase of 5-mC controls glioblastoma response to temozolomide (TMZ) via NELFB and RPS6KB2 interactionChidiebere U Awah, Jan Winter, Claudiane M Mazdoom, et al.Cancer Biology & Therapy|February 7, 2022
Partial treatment response to capmatinib in MET-amplified metastatic intrahepatic cholangiocarcinoma: case report & review of literatureDaniel S Lefler, Marni Brisson Tierno, Babar BashirCancer Biology & Therapy|February 7, 2022
Drugging the undruggable: activity-based protein profiling offers opportunities for targeting the KLK activomeKristi Y Lee, Cindy H Chau, Douglas K Price, et al.Cancer Biology & Therapy|February 23, 2022
Personalized functional profiling using ex-vivo patient-derived spheroids points out the potential of an antiangiogenic treatment in a patient with a metastatic lung atypical carcinoidHichul Kim, Victoria El-Khoury, Nadine Schulte, et al.Cancer Biology & Therapy|February 7, 2022
The Anti-fibrosis drug Pirfenidone modifies the immunosuppressive tumor microenvironment and prevents the progression of renal cell carcinoma by inhibiting tumor autocrine TGF-βGang Wang, Xiaowan Zhou, Zengli Guo, et al.Cancer Biology & Therapy|November 1, 2021
Biguanide drugs enhance cytotoxic effects of cisplatin by depleting aspartate and NAD+ in sensitive cancer cellsEllen Tully, Santosh Bharti, Juhyung Woo, et al.Cancer Biology & Therapy|April 7, 2022
Epigenetic drugs induce the potency of classic chemotherapy, suppress post-treatment re-growth of breast cancer, but preserve the wound healing ability of stem cellsAndrew Zheng, Michelle Bilbao, Janhvi Sookram, et al.Cancer Biology & Therapy|December 12, 2023
Chaperonin containing TCP1 subunit 6A may activate Notch and Wnt pathways to facilitate the malignant behaviors and cancer stemness in oral squamous cell carcinomaYangyi Chen, Yongge Chen, Weixian LiuPageof 387